免疫調節劑市場：按產品類型、應用、最終用戶和地區分類

Immunomodulators Market, By Product Type, By Application, By End User, By Geography

出版日期: 2026年07月03日 | 出版商:

Coherent Market Insights | 英文 252 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，免疫調節藥物市場規模將達2,638億美元，到2033年將達4,164億美元。預計從2026年到2033年，該市場將以6.7%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	2638億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.70%	2033年市場規模預測：	4164億美元

免疫調節劑是一種能夠刺激或抑制免疫系統的藥物。它們透過作用於免疫系統來影響免疫反應。免疫調節劑的作用機轉是減少針對外來抗原產生的抗體數量，進而抑制免疫反應。免疫抑制劑和免疫促效劑是免疫調節劑的兩個不同類別。皮質類固醇、胸腺素和免疫球蛋白都是免疫調節劑的例子。這些藥物用於治療癌症、感染疾病、氣喘和其他疾病。免疫抑制劑常用於各種移植手術中，以防止移植排斥反應。免疫促效劑可用於治療愛滋病和癌症。

發炎性腸道疾病（IBD），特別是潰瘍性大腸炎（UC）和克隆氏症（CD），可採用免疫調節藥物有效治療。免疫調節藥物也廣泛用於器官移植和自體免疫疾病的治療。類固醇可與免疫調節藥物合併使用，以加速其療效。這些藥物也用於現代疫苗製劑，並在製藥領域發揮重要作用。免疫調節的重點在於調控免疫系統，以減少感染疾病和其他不良健康影響，並進行精確控制，從而避免諸如反覆發作的肺炎、支氣管炎、鼻竇炎、中耳炎、腦膜炎和皮膚感染疾病等問題。同時，人們也在努力透過抑製或增強免疫反應來改善動物和人類的健康。

市場動態

類風濕性關節炎、全身性紅斑性狼瘡（紅斑性狼瘡）、幼年型類風濕性關節炎、發炎性腸道疾病和乾癬性關節炎等自體免疫疾病的日益流行，是推動全球免疫調節藥物市場擴張的主要因素。例如，根據美國國立衛生研究院 (NIH) 統計，2017 年美國有多達 2,350 萬人口（約佔總人口的 7%）患有自體免疫疾病，這導致患者群體不斷擴大，進而推動了市場規模的擴張。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數介紹了全球免疫調節產品市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和市場策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球免疫調節劑市場報告的目標受群眾外包括行業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用免疫調節藥物市場分析中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第8章競爭情勢

熱圖分析
市佔率分析
公司簡介
- F. Hoffmann-La Roche Ltd.
- Biogen Inc.
- Teva Pharmaceutical Industries Ltd.
- Novartis AG
- Amgen, Inc.
- Bristol-Myers Squibb Company
- Merck Sharp & Dohme Corp.
- Eli Lilly and Company
- Abbott Laboratories
- Johnson & Johnson
- Pfizer Inc.
分析師意見

第9章

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI4609

Immunomodulators Market is estimated to be valued at USD 263.8 Bn in 2026 and is expected to reach USD 416.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 263.8 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.70%	2033 Value Projection:	USD 416.4 Bn

Immunomodulators are medications that either stimulate or inhibit the immune system. They affect the immunological response by modifying the immune system. Immunomodulators function by lowering the amount of antibodies produced in response to foreign antigens, which stimulate immune reactions. Immunosuppressants and immunostimulants are two different categories of immunomodulators. Corticosteroids, thymosin, and immunoglobulins are a few of the Immunomodulators. Cancer, infection, asthma, and other disorders are treated with these drugs. Immunosuppressants are commonly used to avoid organ rejection during various transplant procedures. Immunostimulants could possibly be utilized to treat HIV and cancer.

Inflammatory bowel disease (IBD), notably ulcerative colitis (UC), and Crohn's disease (CD), can be effectively treated with immunomodulators. Immunomodulators are also commonly employed in organ transplants and the treatment of autoimmune illnesses. Steroids are sometimes taken in conjunction with immunomodulators to speed up the effect of immunomodulators. They are used in contemporary vaccination formulations and play an important role in pharmaceuticals. Immunomodulation focuses on manipulating the immune system to reduce infections and other negative health impacts while maintaining precise control to avoid problems such as frequent and recurrent pneumonia, bronchitis, sinus infections, ear infections, meningitis or skin infections, and others. Simultaneously, efforts to improve animal and human health by suppressive or potentiating measures are made.

Market Dynamics

The rising prevalence of autoimmune illnesses such as rheumatoid arthritis, systemic lupus erythematosus (Lupus), juvenile rheumatoid arthritis, inflammatory bowel arthritis, Psoriatic arthritis, and others is a major contributor to the global immunomodulators market's expansion. For instance, according to the National Institutes of Health, up to 23.5 million Americans (almost 7% of the population) had an autoimmune disease in 2017, resulting in a larger patient pool and, in turn, a larger market.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Global Immunomodulators market based on the following parameters - company highlights, types portfolio, key highlights, financial performance, and market strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd., Biogen Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Amgen, Inc., Bristol-Myers Squibb Company, Merck Sharp & Dohme Corp., Eli Lilly and Company, Abbott Laboratories, Johnson & Johnson, and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global immunomodulators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the immunomodulators market

Market Segmentation

By Product Type (Revenue, USD Bn, 2021-2033)
Immunosuppressants
- Calcineurin Inhibitors
- Glucocorticoids
- Antimetabolites
- Others
Immunostimulants
- Vaccines
- Antibodies
- Others
By Application (Revenue, USD Bn, 2021-2033)
Oncology
Respiratory
HIV
Others
By End User (Revenue, USD Bn, 2021-2033)
Hospitals
Clinics
Others
By Region (Revenue, USD Bn, 2021-2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC
- Israel
- Rest of Middle East
Africa
- South Africa
- Central Africa
- North Africa
Key Players
F.Hoffmann-La Roche Ltd.
Biogen Inc.
Teva Pharmaceutical Industries Ltd.
Novartis AG
Amgen, Inc.
Bristol-Myers Squibb Company
Merck Sharp & Dohme Corp.
Eli Lilly and Company
Abbott Laboratories
Johnson & Johnson
Pfizer Inc.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Key Developments
Disease Type Approval
Collaboration/Merge/Acquisition
Regulatory Landscape
PEST Analysis
Porter's Five Forces Analysis
Epidemiology
Robust Pipeline Analysis

4. Global Immunomodulators Market, By Product Type, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Immunosuppressants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Segment Trends
Calcineurin Inhibitors
Glucocorticoids
Antimetabolites
Others
Immunostimulants
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
- Segment Trends
Vaccines
Antibodies
Others

5. Global Immunomodulators Market, By Application, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Respiratory
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

6. Global Immunomodulators Market, By End User, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022- 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)

7. Global Immunomodulators Market, By Region, 2021 - 2033, (USD Billion)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Billion)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (USD Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Billion)
  - North Africa
  - Central Africa
  - South Africa

8. Competitive Landscape

Heat Map Analysis
Market Share Analysis
Company Profile
- F. Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Biogen Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Teva Pharmaceutical Industries Ltd.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Amgen, Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Bristol-Myers Squibb Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Merck Sharp & Dohme Corp.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Eli Lilly and Company
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Abbott Laboratories
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Johnson & Johnson
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Financial Performance
  - Recent Highlights
  - Market Strategies
Analyst Views